Skip to main content

Jacob Niall Schroder

Assistant Professor of Surgery
Surgery, Cardiovascular and Thoracic Surgery
DUMC 3642, Durham, NC 27710
DUMC 3642, Durham, NC 27710

Selected Grants


Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Clinical TrialPrincipal Investigator · Awarded by AtriCure, Inc. · 2024 - 2034

PRESERVE Heart Study - Pro00113642

Clinical TrialPrincipal Investigator · Awarded by XVIVO Perfusion Inc. · 2023 - 2033

OCS Heart Registry - Pro00109858

Clinical TrialPrincipal Investigator · Awarded by TransMedics · 2022 - 2027

Guardian Registry

Clinical TrialPrincipal Investigator · Awarded by Paragonix · 2021 - 2026

Study of the safety and effectiveness of VEST, Venous External Support

Clinical TrialPrincipal Investigator · Awarded by Vascular Graft Solutions Inc. · 2018 - 2024

OCS Heart EXPAND CAP

Clinical TrialPrincipal Investigator · Awarded by TransMedics · 2019 - 2023

Targeted, Highly Sensitive, Non-Invasive Cardiac Transplant Rejection Monitoring

Clinical TrialPrincipal Investigator · Awarded by Natera, Inc · 2016 - 2022

EXPAND Heart Trial

Clinical TrialPrincipal Investigator · Awarded by TransMedics · 2015 - 2022

AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)

Clinical TrialPrincipal Investigator · Awarded by AtriCure, Inc. · 2017 - 2018

Highly Sensitive Transplant Rejection Monitoring Using Donor Specific DNA

ResearchPrincipal Investigator · Awarded by Medical College of Wisconsin · 2013 - 2018

Expanding the Donor Pool for Heart Transplantation

ResearchInvestigator · Awarded by National Institutes of Health · 2012 - 2014

Myocardial Gene Transfer During Simulated Heart Surgery

FellowshipPI-Fellow · Awarded by National Institutes of Health · 2003 - 2005

External Relationships


  • Abbott Laboratories
  • Abiomed, Inc. (now acquired by Johnson & Johnson)

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.